Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial

200859 citationsJournal Article

Authors

Stephen G. Ellis · Cleveland Clinic

Charles O’Shaughnessy · Memorial Hospital

Sandra L. Martin · CHI Health Nebraska Heart

K.M. Kent · MedStar Washington Hospital Center

Trudy McGarry · Oklahoma Heart Institute

Mark Turco · Washington Adventist Hospital

Dean J. Kereiakes ·

Abstract

Freedom from clinical restenosis at 2 years is significantly enhanced after PES placement compared with VBT for bare metal stent ISR, with similar rates of death, myocardial infarction, and target vessel thrombosis.

Topics & Keywords

Coronary Interventions and Diagnostics Cerebrovascular and Carotid Artery Diseases Cardiac Imaging and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 29, Issue 13, pp. 1625-1634

DOI: 10.1093/eurheartj/ehn231

Field-Weighted Citation Impact: 8.62